Table 1 Summary of COVID-19 cohort characteristics
Cohort Characteristics | N (%) |
|---|---|
Male | 24 (66.7) |
Race (White) | 18 (77.8) |
BMI > 30 | 23 (63.9) |
ARDS diagnosis | 24 (66.7) |
Antibiotics | 26 (73.0) |
Corticosteroid therapy | 29 (81.1) |
Hemodialysis | 6 (16.7) |
Thrombosis | 11 (30.8) |
Deceased | 9 (25.0) |
Median [IQR] | |
Age (years) | 64.5 [56.5, 71.8] |
# days from ICU admission t1 (n = 22) | 7 [3.0, 10.5] |
# days from hospital admission t1 (n = 14) | 1 [0, 2] |
ICUFD | 21.5 [-0.75, 28] |
t1 SOFA-score | 2.5 [1.0, 6.8] |
t2 SOFA-score | 1 [0, 4.8] |
t1 SF-ratio | 242.5 [135.3, 350.8] |
t2 SF-ratio | 334.5 [241.0, 441.8] |
t1 NLR | 7.7 [4.9, 14.6] |
t1 ANC | 4.3 [1.5, 8.9] |
% t1 [DEspR + CD11b + NET + Ns] | 53.85 [28.2, 68.6] |
% t1 [DEspR + CD11b + NET(-) Ns] | 46.15 [31.5, 71.8] |
% t1 [DEspR(-)CD11b( ±) NET + Ns] | 0.94 [0.17, 3.00] |
# t1 [DEspR + CD11b + NET + Ns] K/μL | 0.18 [0.02, 0.95] |
# t1 [DEspR + CD11b + NET(-) Ns] K/μL | 0.15 [0.018, 1.1] |
# t1 [DEspR(-)CD11b( ±) NET + Ns] K/μL | 0.03 [0.006, 0.080] |
Ave [min–max] | |
# t1 [DEspR + CD11b + NET + Ns] K/μL | 1.53 [0–15.4] |
# t1 [DEspR + CD11b + NET(-) Ns] K/μL | 1.08 [0–7.9] |
# t1 [DEspR(-)CD11b( ±) NET + Ns] K/μL | 0.11 [0–0.84 |